Cargando…
Targeting the Mycobacterium tuberculosis transpeptidase Ldt(Mt2) with cysteine-reactive inhibitors including ebselen
The l,d-transpeptidases (Ldts) are promising antibiotic targets for treating tuberculosis. We report screening of cysteine-reactive inhibitors against Ldt(Mt2) from Mycobacterium tuberculosis. Structural studies on Ldt(Mt2) with potent inhibitor ebselen reveal opening of the benzisoselenazolone ring...
Autores principales: | de Munnik, Mariska, Lohans, Christopher T., Lang, Pauline A., Langley, Gareth W., Malla, Tika R., Tumber, Anthony, Schofield, Christopher J., Brem, Jürgen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Royal Society of Chemistry
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6984337/ https://www.ncbi.nlm.nih.gov/pubmed/31380528 http://dx.doi.org/10.1039/c9cc04145a |
Ejemplares similares
-
A Fluorescence‐Based Assay for Screening β‐Lactams Targeting the Mycobacterium tuberculosis Transpeptidase Ldt(Mt2)
por: de Munnik, Mariska, et al.
Publicado: (2019) -
High-throughput screen with the l,d-transpeptidase Ldt(Mt2) of Mycobacterium tuberculosis reveals novel classes of covalently reacting inhibitors
por: de Munnik, Mariska, et al.
Publicado: (2023) -
Non‐Hydrolytic β‐Lactam Antibiotic Fragmentation by l,d‐Transpeptidases and Serine β‐Lactamase Cysteine Variants
por: Lohans, Christopher T., et al.
Publicado: (2019) -
Structure of Ldt(Mt2), an l,d-transpeptidase from Mycobacterium tuberculosis
por: Böth, Dominic, et al.
Publicado: (2013) -
Structural insight into the inactivation of Mycobacterium tuberculosis non-classical transpeptidase Ldt(Mt2) by biapenem and tebipenem
por: Bianchet, Mario A., et al.
Publicado: (2017)